EA201270774A1 - Способ уменьшения биопленок - Google Patents
Способ уменьшения биопленокInfo
- Publication number
- EA201270774A1 EA201270774A1 EA201270774A EA201270774A EA201270774A1 EA 201270774 A1 EA201270774 A1 EA 201270774A1 EA 201270774 A EA201270774 A EA 201270774A EA 201270774 A EA201270774 A EA 201270774A EA 201270774 A1 EA201270774 A1 EA 201270774A1
- Authority
- EA
- Eurasian Patent Office
- Prior art keywords
- gram
- relates
- bacterial biofilms
- formation
- food
- Prior art date
Links
- 238000000034 method Methods 0.000 title abstract 2
- 230000001580 bacterial effect Effects 0.000 abstract 4
- 235000013305 food Nutrition 0.000 abstract 4
- 230000015572 biosynthetic process Effects 0.000 abstract 3
- 102000037865 fusion proteins Human genes 0.000 abstract 3
- 108020001507 fusion proteins Proteins 0.000 abstract 3
- 241000192125 Firmicutes Species 0.000 abstract 2
- 108010062010 N-Acetylmuramoyl-L-alanine Amidase Proteins 0.000 abstract 2
- 239000002158 endotoxin Substances 0.000 abstract 2
- 208000015181 infectious disease Diseases 0.000 abstract 2
- 229920006008 lipopolysaccharide Polymers 0.000 abstract 2
- 230000002265 prevention Effects 0.000 abstract 2
- 108010062877 Bacteriocins Proteins 0.000 abstract 1
- 239000002537 cosmetic Substances 0.000 abstract 1
- 239000000645 desinfectant Substances 0.000 abstract 1
- 239000003814 drug Substances 0.000 abstract 1
- 229940079593 drug Drugs 0.000 abstract 1
- 230000000694 effects Effects 0.000 abstract 1
- 230000008030 elimination Effects 0.000 abstract 1
- 238000003379 elimination reaction Methods 0.000 abstract 1
- 230000007613 environmental effect Effects 0.000 abstract 1
- KDXKERNSBIXSRK-UHFFFAOYSA-N lysine Chemical compound NCCCCC(N)C(O)=O KDXKERNSBIXSRK-UHFFFAOYSA-N 0.000 abstract 1
- 239000012528 membrane Substances 0.000 abstract 1
- 108090000765 processed proteins & peptides Proteins 0.000 abstract 1
- 230000009467 reduction Effects 0.000 abstract 1
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K19/00—Hybrid peptides, i.e. peptides covalently bound to nucleic acids, or non-covalently bound protein-protein complexes
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K38/00—Medicinal preparations containing peptides
- A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
- A61K38/43—Enzymes; Proenzymes; Derivatives thereof
- A61K38/46—Hydrolases (3)
- A61K38/47—Hydrolases (3) acting on glycosyl compounds (3.2), e.g. cellulases, lactases
-
- A—HUMAN NECESSITIES
- A01—AGRICULTURE; FORESTRY; ANIMAL HUSBANDRY; HUNTING; TRAPPING; FISHING
- A01N—PRESERVATION OF BODIES OF HUMANS OR ANIMALS OR PLANTS OR PARTS THEREOF; BIOCIDES, e.g. AS DISINFECTANTS, AS PESTICIDES OR AS HERBICIDES; PEST REPELLANTS OR ATTRACTANTS; PLANT GROWTH REGULATORS
- A01N37/00—Biocides, pest repellants or attractants, or plant growth regulators containing organic compounds containing a carbon atom having three bonds to hetero atoms with at the most two bonds to halogen, e.g. carboxylic acids
- A01N37/44—Biocides, pest repellants or attractants, or plant growth regulators containing organic compounds containing a carbon atom having three bonds to hetero atoms with at the most two bonds to halogen, e.g. carboxylic acids containing at least one carboxylic group or a thio analogue, or a derivative thereof, and a nitrogen atom attached to the same carbon skeleton by a single or double bond, this nitrogen atom not being a member of a derivative or of a thio analogue of a carboxylic group, e.g. amino-carboxylic acids
- A01N37/46—N-acyl derivatives
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K38/00—Medicinal preparations containing peptides
- A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K38/00—Medicinal preparations containing peptides
- A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
- A61K38/43—Enzymes; Proenzymes; Derivatives thereof
- A61K38/46—Hydrolases (3)
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K45/00—Medicinal preparations containing active ingredients not provided for in groups A61K31/00 - A61K41/00
- A61K45/06—Mixtures of active ingredients without chemical characterisation, e.g. antiphlogistics and cardiaca
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
- A61P1/02—Stomatological preparations, e.g. drugs for caries, aphtae, periodontitis
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P27/00—Drugs for disorders of the senses
- A61P27/02—Ophthalmic agents
- A61P27/04—Artificial tears; Irrigation solutions
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
- A61P31/04—Antibacterial agents
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N15/00—Mutation or genetic engineering; DNA or RNA concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
- C12N15/09—Recombinant DNA-technology
- C12N15/11—DNA or RNA fragments; Modified forms thereof; Non-coding nucleic acids having a biological activity
- C12N15/62—DNA sequences coding for fusion proteins
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N9/00—Enzymes; Proenzymes; Compositions thereof; Processes for preparing, activating, inhibiting, separating or purifying enzymes
- C12N9/14—Hydrolases (3)
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N9/00—Enzymes; Proenzymes; Compositions thereof; Processes for preparing, activating, inhibiting, separating or purifying enzymes
- C12N9/14—Hydrolases (3)
- C12N9/24—Hydrolases (3) acting on glycosyl compounds (3.2)
- C12N9/2402—Hydrolases (3) acting on glycosyl compounds (3.2) hydrolysing O- and S- glycosyl compounds (3.2.1)
- C12N9/2462—Lysozyme (3.2.1.17)
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N9/00—Enzymes; Proenzymes; Compositions thereof; Processes for preparing, activating, inhibiting, separating or purifying enzymes
- C12N9/14—Hydrolases (3)
- C12N9/48—Hydrolases (3) acting on peptide bonds (3.4)
- C12N9/50—Proteinases, e.g. Endopeptidases (3.4.21-3.4.25)
- C12N9/52—Proteinases, e.g. Endopeptidases (3.4.21-3.4.25) derived from bacteria or Archaea
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12Y—ENZYMES
- C12Y302/00—Hydrolases acting on glycosyl compounds, i.e. glycosylases (3.2)
- C12Y302/01—Glycosidases, i.e. enzymes hydrolysing O- and S-glycosyl compounds (3.2.1)
- C12Y302/01017—Lysozyme (3.2.1.17)
-
- Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
- Y02—TECHNOLOGIES OR APPLICATIONS FOR MITIGATION OR ADAPTATION AGAINST CLIMATE CHANGE
- Y02A—TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE
- Y02A50/00—TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE in human health protection, e.g. against extreme weather
- Y02A50/30—Against vector-borne diseases, e.g. mosquito-borne, fly-borne, tick-borne or waterborne diseases whose impact is exacerbated by climate change
Landscapes
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Engineering & Computer Science (AREA)
- Organic Chemistry (AREA)
- Genetics & Genomics (AREA)
- Bioinformatics & Cheminformatics (AREA)
- General Health & Medical Sciences (AREA)
- Zoology (AREA)
- Wood Science & Technology (AREA)
- Medicinal Chemistry (AREA)
- Biochemistry (AREA)
- Biomedical Technology (AREA)
- General Engineering & Computer Science (AREA)
- Molecular Biology (AREA)
- Biotechnology (AREA)
- Microbiology (AREA)
- Veterinary Medicine (AREA)
- Animal Behavior & Ethology (AREA)
- Public Health (AREA)
- Pharmacology & Pharmacy (AREA)
- Proteomics, Peptides & Aminoacids (AREA)
- Epidemiology (AREA)
- Gastroenterology & Hepatology (AREA)
- Biophysics (AREA)
- Immunology (AREA)
- Plant Pathology (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- General Chemical & Material Sciences (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Physics & Mathematics (AREA)
- Pest Control & Pesticides (AREA)
- Dentistry (AREA)
- Environmental Sciences (AREA)
- Agronomy & Crop Science (AREA)
- Oncology (AREA)
- Communicable Diseases (AREA)
- Ophthalmology & Optometry (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
- Peptides Or Proteins (AREA)
Abstract
Заявленное изобретение относится к способам устранения, уменьшения или предотвращения бактериальных биопленок с использованием слитого белка, содержащего эндолизин, аутолизин или бактериоцин, с которым слит пептид, обладающий активностью, разрушающей мембрану или липополисахарид (ЛПС). Помимо этого заявленное изобретение относится к слитым белкам, применяемым в качестве лекарственного препарата, в частности, для лечения или профилактики инфекций, вызванных грамотрицательными и/или грамположительными бактериями, связанных с образованием бактериальных биопленок, в качестве диагностического средства, дезинфектанта или компонента косметического препарата. Заявленное изобретение также относится к устранению, уменьшению или предотвращению заражения грамотрицательными и/или грамположительными бактериями, связанного с образованием бактериальных биопленок, пищевых продуктов, оборудования и помещений на предприятиях пищевой промышленности, поверхностей, контактирующих с пищевыми продуктами, медицинского оборудования, поверхностей в медицинских стационарах и хирургических блоках. Более того, заявленное изобретение относится к применению вышеупомянутого слитого белка в качестве диагностического средства в медицинской, пищевой отраслях промышленности и охране окружающей среды, связанных с образованием бактериальных биопленок.
Applications Claiming Priority (2)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
EP10161170 | 2010-04-27 | ||
PCT/EP2011/056657 WO2011134998A1 (en) | 2010-04-27 | 2011-04-27 | Method of reducing biofilms |
Publications (2)
Publication Number | Publication Date |
---|---|
EA201270774A1 true EA201270774A1 (ru) | 2013-04-30 |
EA037276B1 EA037276B1 (ru) | 2021-03-03 |
Family
ID=44201821
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
EA201270774A EA037276B1 (ru) | 2010-04-27 | 2011-04-27 | Способы устранения или уменьшения бактериальной биопленки |
Country Status (16)
Country | Link |
---|---|
US (2) | US9534223B2 (ru) |
EP (1) | EP2563916B1 (ru) |
JP (2) | JP2013532955A (ru) |
KR (1) | KR20130100062A (ru) |
CN (1) | CN103119158B (ru) |
AU (1) | AU2011247584B2 (ru) |
BR (1) | BR112012026880B1 (ru) |
CA (1) | CA2794603C (ru) |
DK (1) | DK2563916T3 (ru) |
EA (1) | EA037276B1 (ru) |
HK (1) | HK1183687A1 (ru) |
IL (1) | IL222713A (ru) |
MX (1) | MX340520B (ru) |
SG (1) | SG184836A1 (ru) |
TW (1) | TWI527521B (ru) |
WO (1) | WO2011134998A1 (ru) |
Families Citing this family (46)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
GB0815484D0 (en) | 2008-08-26 | 2008-10-01 | Univ Leuven Kath | Antibacterial agents |
BRPI1015203B1 (pt) | 2009-06-26 | 2021-06-01 | Lysando Ag | Proteína de fusão composta por uma endolisina e uma extensão de peptídeo anfifática, usos da mesma e composição farmacêutica que compreende a dita proteína |
KR20170024129A (ko) | 2009-06-26 | 2017-03-06 | 카톨리에케 유니버시테이트 루벤 | 항균제 |
CN102575240B (zh) * | 2009-08-24 | 2016-01-13 | 勒芬天主教大学,K.U.勒芬R&D | 新的细胞内溶素OBPgpLYS |
CN103119158B (zh) * | 2010-04-27 | 2015-04-08 | 莱桑多公司 | 减少生物膜的方法 |
EP2468856A1 (en) * | 2010-12-23 | 2012-06-27 | Lysando Aktiengesellschaft | Antimicrobial Agents |
AU2011367262B2 (en) * | 2011-05-04 | 2016-11-03 | Micreos Human Health B.V. | A polypeptide |
BR112014023068B1 (pt) * | 2012-03-23 | 2022-03-03 | Amicrobe, Inc | Composição aquosa para prevenir, inibir ou tratar infecção e respectivo uso |
MX369056B (es) * | 2012-05-09 | 2019-10-28 | Contrafect Corp | Prevención, interrupción y tratamiento de biopelículas con lisina de bacteriófago. |
US9388400B2 (en) | 2012-06-29 | 2016-07-12 | Lysando Ag | Composition for use in mycobacteria diagnosis |
EP2679677A1 (en) * | 2012-06-29 | 2014-01-01 | Lysando Aktiengesellschaft | Composition for use in Mycobacteria therapy |
CN102949750B (zh) * | 2012-11-15 | 2014-11-05 | 中国人民解放军第三军医大学 | 双层电纺仿生骨膜及其制备 |
DE102013106455A1 (de) * | 2013-06-20 | 2014-12-24 | Airbus Defence and Space GmbH | Verfahren zur Dekontamination von bakteriologischen Verunreinigungen |
WO2015038731A1 (en) * | 2013-09-12 | 2015-03-19 | The Johns Hopkins University | Biofilm formation to define risk for colon cancer |
WO2015070911A1 (en) * | 2013-11-14 | 2015-05-21 | Lysando Ag | Modified kz144 endolysin sequence |
WO2015070912A1 (en) * | 2013-11-14 | 2015-05-21 | Lysando Ag | Modified el188 endolysin sequence |
US10329550B2 (en) | 2014-02-14 | 2019-06-25 | Lysando Ag | Antimicrobial agents |
EP3129044B1 (en) * | 2014-04-08 | 2022-09-07 | Lysando AG | Peptidoglycan hydrolase for use in the treatment of chronic bacterial infections |
BR112016030580B1 (pt) | 2014-06-26 | 2023-12-19 | The Rockefeller University | Polipeptídeo de lisina e fragmento de polipeptídeo com atividade para matar bactérias gram-negativas |
CN107207570A (zh) * | 2014-09-01 | 2017-09-26 | 弗拉芒区生物技术研究所 | 突变csgg孔 |
WO2016130024A1 (en) * | 2015-02-13 | 2016-08-18 | Supreme Biotechnologies Limited | Endolysin expression platform |
TW201710282A (zh) * | 2015-09-04 | 2017-03-16 | 佛教慈濟醫療財團法人 | 衍生自鮑氏不動桿菌噬菌體之新穎抗菌胜肽及其用途 |
AU2017264967A1 (en) * | 2016-05-12 | 2019-01-03 | The Trustees Of The University Of Pennsylvania | Compositions and methods for inhibiting biofilm deposition and production |
CN106854247A (zh) * | 2016-12-12 | 2017-06-16 | 华南农业大学 | 一种可以裂解大肠杆菌及沙门氏菌的噬菌体裂解酶的制备方法 |
WO2018109229A1 (en) * | 2016-12-16 | 2018-06-21 | Universidade Do Minho | Novel endolysin |
EP3378485A1 (en) * | 2017-03-24 | 2018-09-26 | Nomad Bioscience GmbH | Bacteriocins for control of salmonella enterica |
SG11201909016TA (en) | 2017-04-06 | 2019-10-30 | Amicrobe Inc | Compositions and uses of locally-applied antimicrobial synthetic cationic polypeptide(s) with enhanced performance and safety |
KR20200024940A (ko) | 2017-07-27 | 2020-03-09 | 로커스 아이피 컴퍼니 엘엘씨 | 의약품, 보충제 및 섭취된 물질의 생체 이용률을 향상시키기 위한 조성물 |
WO2019046577A1 (en) * | 2017-08-31 | 2019-03-07 | Syngulon Sa | METHODS AND COMPOSITIONS FOR THE PRODUCTION OF BACTERIOCIN AND ANTIMICROBIAL PEPTIDES |
CN107723280B (zh) * | 2017-11-10 | 2019-09-17 | 扬州大学 | 波罗的海希瓦氏菌噬菌体SppYZU01及其用途 |
CN111971058A (zh) * | 2017-12-12 | 2020-11-20 | 康特拉费克特公司 | 对铜绿假单胞菌具有细菌活性的溶素及其衍生物的鉴定 |
EP3731643A4 (en) | 2017-12-26 | 2021-12-29 | Locus IP Company, LLC | Organic food preservative compositions |
CN108251330B (zh) * | 2017-12-28 | 2021-03-23 | 江苏世邦生物工程科技有限公司 | 用于治理土壤污染的复合微生物菌剂及其制备方法和应用 |
CA3085343A1 (en) | 2017-12-28 | 2019-07-04 | Locus Ip Company, Llc | Oral health composition comprising purified biosurfactants and/or their derivatives |
KR20210014673A (ko) | 2018-05-30 | 2021-02-09 | 뤼산도 아게 | 신규 항균성 단백질 |
AU2019276252A1 (en) | 2018-05-30 | 2020-11-26 | Lysando Ag | Novel antimicrobial fusion proteins |
MX2021013491A (es) * | 2019-05-08 | 2022-02-21 | Phagomed Biopharma Gmbh | Nuevas endolisinas de gardnerella y usos de las mismas. |
SG11202112387UA (en) * | 2019-05-10 | 2021-12-30 | Locus Ip Co Llc | Compositions and methods for treating biofilm-related lung conditions |
ES2895800B2 (es) * | 2019-10-10 | 2024-01-22 | Univ Alicante | USOS DE PROTEINAS VIRICAS CON ACTIVIDAD ANTIBACTERIANA FRENTE A Escherichia coli |
KR20220163970A (ko) | 2020-03-19 | 2022-12-12 | 마이크레오스 휴먼 헬스 비.브이. | 안정화된 목적 단백질 |
CN111876400B (zh) * | 2020-08-06 | 2022-05-24 | 昆明理工大学 | 一种常温裂解酶Sly和编码此酶的多核苷酸 |
CN114908077A (zh) * | 2021-02-08 | 2022-08-16 | 武汉乐斯吉生物科技有限公司 | 噬菌体裂解酶、其嵌合物及应用 |
CA3213821A1 (en) | 2021-03-19 | 2022-09-22 | Eligo Bioscience | Therapeutic use of engineered postbiotics comprising bacteriocins and/or endolysins |
WO2022195108A2 (en) | 2021-03-19 | 2022-09-22 | Eligo Bioscience | Cosmetic use of engineered postbiotics comprising bacteriocins and/or endolysins |
WO2023089544A1 (en) * | 2021-11-18 | 2023-05-25 | Sasinapas Co., Ltd. | Pharmaceutical composition comprising an endolysin or an artilysin and an anti-cancer agent |
KR102551061B1 (ko) * | 2022-05-26 | 2023-07-03 | 중앙대학교 산학협력단 | Saha를 유효성분으로 포함하는 살모넬라 속 균주에 의한 바이오필름 생성 저해용 조성물 |
Family Cites Families (8)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
GB8816693D0 (en) | 1988-07-13 | 1988-08-17 | Agricultural & Food Res | Viral enzyme & gene |
US20020037260A1 (en) * | 1997-10-16 | 2002-03-28 | Budny John A. | Compositions for treating biofilm |
CA2661634C (en) | 2006-09-06 | 2017-03-28 | The Regents Of The University Of California | Selectively targeted antimicrobial peptides and the use thereof |
MX340736B (es) * | 2007-09-25 | 2016-07-22 | Pastoral Greenhouse Gas Res Ltd * | Vacunas y componentes de vacunas para inhibicion de celulas microbianas. |
GB0815484D0 (en) | 2008-08-26 | 2008-10-01 | Univ Leuven Kath | Antibacterial agents |
GB0905451D0 (en) * | 2009-03-31 | 2009-05-13 | Novabiotics Ltd | Biofilms |
KR20170024129A (ko) * | 2009-06-26 | 2017-03-06 | 카톨리에케 유니버시테이트 루벤 | 항균제 |
CN103119158B (zh) * | 2010-04-27 | 2015-04-08 | 莱桑多公司 | 减少生物膜的方法 |
-
2011
- 2011-04-27 CN CN201180032048.5A patent/CN103119158B/zh active Active
- 2011-04-27 MX MX2012012345A patent/MX340520B/es active IP Right Grant
- 2011-04-27 BR BR112012026880-5A patent/BR112012026880B1/pt active IP Right Grant
- 2011-04-27 DK DK11718001.8T patent/DK2563916T3/en active
- 2011-04-27 JP JP2013506649A patent/JP2013532955A/ja active Pending
- 2011-04-27 KR KR1020127031100A patent/KR20130100062A/ko not_active Application Discontinuation
- 2011-04-27 WO PCT/EP2011/056657 patent/WO2011134998A1/en active Application Filing
- 2011-04-27 AU AU2011247584A patent/AU2011247584B2/en active Active
- 2011-04-27 EA EA201270774A patent/EA037276B1/ru not_active IP Right Cessation
- 2011-04-27 US US13/643,900 patent/US9534223B2/en active Active
- 2011-04-27 CA CA2794603A patent/CA2794603C/en active Active
- 2011-04-27 TW TW100114595A patent/TWI527521B/zh active
- 2011-04-27 EP EP11718001.8A patent/EP2563916B1/en active Active
- 2011-04-27 SG SG2012075933A patent/SG184836A1/en unknown
-
2012
- 2012-10-25 IL IL222713A patent/IL222713A/en active IP Right Grant
-
2013
- 2013-08-15 HK HK13109541.0A patent/HK1183687A1/xx unknown
-
2016
- 2016-07-19 JP JP2016141499A patent/JP2016208985A/ja active Pending
- 2016-12-20 US US15/384,564 patent/US10485854B2/en active Active
Also Published As
Publication number | Publication date |
---|---|
JP2016208985A (ja) | 2016-12-15 |
CA2794603A1 (en) | 2011-11-03 |
TWI527521B (zh) | 2016-04-01 |
IL222713A (en) | 2017-08-31 |
DK2563916T3 (en) | 2015-10-05 |
MX2012012345A (es) | 2013-05-20 |
MX340520B (es) | 2016-07-12 |
KR20130100062A (ko) | 2013-09-09 |
TW201204262A (en) | 2012-02-01 |
IL222713A0 (en) | 2012-12-31 |
BR112012026880A2 (pt) | 2015-09-22 |
JP2013532955A (ja) | 2013-08-22 |
AU2011247584B2 (en) | 2016-01-14 |
AU2011247584A1 (en) | 2012-10-11 |
EP2563916A1 (en) | 2013-03-06 |
WO2011134998A8 (en) | 2011-12-15 |
CN103119158B (zh) | 2015-04-08 |
EP2563916B1 (en) | 2015-07-08 |
CN103119158A (zh) | 2013-05-22 |
SG184836A1 (en) | 2012-11-29 |
EA037276B1 (ru) | 2021-03-03 |
US20130052182A1 (en) | 2013-02-28 |
US10485854B2 (en) | 2019-11-26 |
WO2011134998A1 (en) | 2011-11-03 |
BR112012026880B1 (pt) | 2021-03-16 |
US9534223B2 (en) | 2017-01-03 |
HK1183687A1 (en) | 2014-01-03 |
CA2794603C (en) | 2019-05-21 |
US20170173121A1 (en) | 2017-06-22 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
EA201270774A1 (ru) | Способ уменьшения биопленок | |
EA201100312A1 (ru) | Антимикробные агенты | |
EA201270079A1 (ru) | Антимикробные агенты | |
EA201270082A1 (ru) | Новые антимикробные агенты | |
EA201270322A1 (ru) | НОВЫЙ ЭНДОЛИЗИН OBPgpLYS | |
EA201370145A1 (ru) | Антимикробные средства | |
GB201018518D0 (en) | Novel endolysin | |
ATE427116T1 (de) | Behandlung von bakteriellen infektionen | |
BR112016016854A2 (pt) | Derivados de 7-oxo-1,6-diazabiciclo[3.2.1]octana, seu processo de preparação e seu uso, composição farmacêutica e seu uso pedidos de patente relacionados | |
ATE534372T1 (de) | Verfahren und zusammensetzungen zur behandlung und prävention von infektionen | |
WO2015002932A8 (en) | Antimicrobial compositions comprising hypochlorous acid and silver | |
UA109557C2 (uk) | Похідні 2-піперазин-1-іл-4h-1,3-бензотіазин-4-ону та їх застосування для лікування інфекцій у ссавців | |
DK2126049T3 (da) | Antistoffer mod humant cytomegalovirus (hCMV) | |
EA201991233A1 (ru) | Новый эндолизин | |
WO2015112980A3 (en) | Dermaseptin-type and piscidin-type antimicrobial peptides | |
EA201491272A1 (ru) | Нанопродукт, содержащий lactobacillus reuteri dan080, подходящий для профилактики и терапии - человеческой и ветеринарной, и его медицинское применение | |
WO2017218922A3 (en) | Compositions and methods for the treatment of bacterial infections | |
EA201890633A1 (ru) | Композиции и способы для многофункциональных растворов для дезинфекции и стерилизации | |
MX2023004933A (es) | Proteinas de fusion de ace2 y usos de las mismas. | |
AU2012335397A8 (en) | Novel bacteriophages | |
BR112015027636A2 (pt) | Uso da composição farmacêutica | |
WO2021081110A3 (en) | Peptides and use thereof | |
BR112014005221A2 (pt) | uso de materiais de fibra oca modificada para a remoção de exotoxinas produzidas por escherichia coli a partir de liquidos, de preferência a partir de sangue e de plasma, bem como seu uso para o tratamento de doenças concomitantes | |
WO2013155320A3 (en) | Use of microbial gene products to prevent or treat microbial infections | |
WO2023006935A3 (en) | Ace2 fusion proteins and uses thereof |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
MM4A | Lapse of a eurasian patent due to non-payment of renewal fees within the time limit in the following designated state(s) |
Designated state(s): AM AZ KZ KG MD TJ TM |